# | Drug | Count |
---|---|---|
0 | NIRAPARIB | 512 |
1 | CYCLOPHOSPHAMIDE | 134 |
2 | IMATINIB MESYLATE | 127 |
3 | METHOTREXATE SODIUM | 112 |
4 | CAPECITABINE | 107 |
5 | METHOTREXATE | 99 |
6 | RITUXIMAB | 94 |
7 | PREDNISONE | 92 |
8 | TRASTUZUMAB | 90 |
9 | CARBOPLATIN | 88 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | LIQUID BANDAGE | 1 | 0.3333 |
1 | NIRAPARIB | 512 | 0.0348 |
2 | DOXORUBICIN HYDROCHLORIDE LIPOSOME | 1 | 0.0116 |
3 | L-GLUTAMINE | 3 | 0.0113 |
4 | FERROUS ASPARTO GLYCINATE, FERROUS FUMARATE, ASCORBIC ACID, FOLIC ACID, CYANOCOBALAMIN, ZINC, AND INTRINSIC FACTOR | 1 | 0.0102 |
5 | DICLOXACILLIN SODIUM | 1 | 0.0089 |
6 | CALCITE | 1 | 0.0086 |
7 | TEA TREE OIL | 1 | 0.0077 |
8 | .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN D | 1 | 0.0074 |
9 | ANIFROLUMAB | 1 | 0.0065 |
# | Drug class | Count |
---|---|---|
0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 552 |
1 | Alkylating Drug [EPC] | 236 |
2 | Nucleoside Metabolic Inhibitor [EPC] | 223 |
3 | Corticosteroid [EPC] | 218 |
4 | Kinase Inhibitor [EPC] | 206 |
5 | Platinum-based Drug [EPC] | 141 |
6 | Aromatase Inhibitor [EPC] | 131 |
7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 114 |
8 | CD20-directed Cytolytic Antibody [EPC] | 99 |
9 | Folate Analog Metabolic Inhibitor [EPC] | 99 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 552 | 0.0227 |
1 | Type I Interferon Receptor Antagonist [EPC] | 1 | 0.0065 |
2 | Actinomycin [EPC] | 10 | 0.0045 |
3 | Vitamin B6 Analog [EPC] | 1 | 0.0042 |
4 | Photoactivated Radical Generator [EPC] | 2 | 0.0036 |
5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 4 | 0.0028 |
6 | Somatostatin Analog [EPC] | 10 | 0.0025 |
7 | Estrogen Receptor Antagonist [EPC] | 43 | 0.0020 |
8 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0020 |
9 | Hedgehog Pathway Inhibitor [EPC] | 14 | 0.0019 |